- Report
- September 2025
- 300 Pages
Global
From €4406EUR$4,995USD£3,871GBP
- Report
- April 2025
- 198 Pages
Global
From €4406EUR$4,995USD£3,871GBP
- Report
- November 2025
- 150 Pages
Global
From €4278EUR$4,850USD£3,758GBP
- Report
- May 2025
- 135 Pages
Global
From €3636EUR$4,123USD£3,195GBP
€4278EUR$4,850USD£3,758GBP
- Report
- November 2025
- 150 Pages
Global
From €3396EUR$3,850USD£2,983GBP
- Report
- October 2025
- 150 Pages
Global
From €2514EUR$2,850USD£2,208GBP
€3396EUR$3,850USD£2,983GBP
- Report
- October 2025
- 160 Pages
Global
From €2962EUR$3,358USD£2,602GBP
€3484EUR$3,950USD£3,061GBP
- Report
- October 2025
- 160 Pages
Global
From €2962EUR$3,358USD£2,602GBP
€3484EUR$3,950USD£3,061GBP
- Report
- October 2025
- 160 Pages
Global
From €2962EUR$3,358USD£2,602GBP
€3484EUR$3,950USD£3,061GBP
- Report
- October 2025
- 160 Pages
Global
From €2962EUR$3,358USD£2,602GBP
€3484EUR$3,950USD£3,061GBP
- Report
- August 2025
- 175 Pages
Global
From €3175EUR$3,599USD£2,789GBP
- Report
- May 2025
- 135 Pages
Global
From €3636EUR$4,123USD£3,195GBP
€4278EUR$4,850USD£3,758GBP
- Report
- April 2025
- 210 Pages
Global
From €3969EUR$4,500USD£3,487GBP
- Report
- May 2025
- 75 Pages
Asia Pacific
From €2867EUR$3,250USD£2,518GBP
- Report
- January 2025
- 72 Pages
Asia Pacific
From €2867EUR$3,250USD£2,518GBP
- Report
- January 2025
- 67 Pages
Europe
From €2867EUR$3,250USD£2,518GBP
- Report
- October 2025
- 89 Pages
Middle East
From €4278EUR$4,850USD£3,758GBP
- Report
- October 2025
- 81 Pages
United States
From €4278EUR$4,850USD£3,758GBP
- Report
- November 2025
- 70 Pages
Middle East, Africa
From €3043EUR$3,450USD£2,673GBP
- Report
- November 2025
- 97 Pages
Asia Pacific
From €3484EUR$3,950USD£3,061GBP

The Genomics Artificial Intelligence (AI) market is a rapidly growing sector of the genomics industry. It is focused on the development of AI-based solutions to enable the analysis of large-scale genomic data. These solutions are used to identify genetic variants associated with diseases, to develop personalized treatments, and to improve the accuracy of diagnostics. AI-based solutions are also used to identify novel drug targets and to develop new drugs.
The Genomics AI market is driven by the increasing availability of genomic data, the need for more accurate and personalized treatments, and the growing demand for AI-based solutions. The market is expected to continue to grow in the coming years, as more genomic data is collected and AI-based solutions become more widely adopted.
Some companies in the Genomics AI market include Illumina, BGI, Thermo Fisher Scientific, Genomics plc, and DNAnexus. Show Less Read more